Contemporary nationwide trends in major adverse cardiovascular events in young cannabis users without concomitant tobacco, alcohol, cocaine use

被引:0
|
作者
Desai, Rupak [1 ]
Gurram, Priyatham [2 ]
Mohammed, Adil S. [2 ]
Salian, Rishabh B. [3 ]
Lingamsetty, Shanmukh Sai Pavan [4 ]
Guntuku, Sandeep [4 ]
Medarametla, Ravi Venkata Sai Krishna [4 ]
Jahan, Rawnak [5 ]
Muslehuddin, Zainab [6 ]
Ghantasala, Paritharsh [2 ]
机构
[1] Dept Outcomes Res, Atlanta, GA 30033 USA
[2] Cent Michigan Univ, Coll Med, Dept Internal Med, 1000 Houghton Ave, Saginaw, MI 48602 USA
[3] Kasturba Med Coll & Hosp, Dept Med, Mangalore 575001, India
[4] Mamata Med Coll, Dept Med, Khammam 507002, India
[5] Bangladesh Med Coll, Dept Med, Dhaka 110015, Bangladesh
[6] Wayne State Univ, Sinai Grace Hosp, Detroit Med Ctr, Dept Internal Med, Detroit, MI 48201 USA
来源
WORLD JOURNAL OF CARDIOLOGY | 2024年 / 16卷 / 09期
关键词
Cannabis; Major adverse cardiac and cerebrovascular events; Myocardial infarction; Cardiac arrest; Stroke; All-cause mortality; Young adults; Trends; ISCHEMIC-STROKE; MARIJUANA USE; RISK;
D O I
10.4330/wjc.v16.i9.512
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Cannabis use has increased among young individuals in recent years. Although dependent cannabis use disorder (CUD) has been associated with various cardiac events, its effects on young adults without concurrent substance use remain understudied. AIM To examine trends in hospitalizations for major adverse cardiac and cerebrovascular events (MACCE) in this cohort. METHODS We used the National Inpatient Sample (2016-2019) to identify hospitalized young individuals (18-44 years), excluding those with concurrent substance usage (tobacco, alcohol, and cocaine). They were divided into CUD+ and CUD-. Using International Classification of Diseases-10 codes, we examined the trends in MACCE hospitalizations, including all-cause mortality (ACM), acute myocardial infarction (AMI), cardiac arrest (CA), and acute ischemic stroke (AIS). RESULTS Of 27.4 million hospitalizations among young adults without concurrent substance abuse, 4.2% (1.1 million) had co-existent CUD. In CUD+ group, hospitalization rates for MACCE (1.71% vs 1.35%), AMI (0.86% vs 0.54%), CA (0.27% vs 0.24%), and AIS (0.49% vs 0.35%) were higher than in CUD- group (P < 0.001). However, rate of ACM hospitalizations was lower in CUD+ group (0.30% vs 0.44%). From 2016 to 2019, CUD+ group experienced a relative rise of 5% in MACCE and 20% in AMI hospitalizations, compared to 22% and 36% increases in CUD- group (P < 0.05). The CUD+ group had a 13% relative decrease in ACM hospitalizations, compared to a 10% relative rise in CUD- group (P < 0.05). However, when adjusted for confounders, MACCE odds among CUD+ cohort remain comparable between 2016 and 2019. CONCLUSION The CUD+ group had higher rates of MACCE, but the rising trends were more apparent in the CUD- group over time. Interestingly, the CUD+ group had lower ACM rates than the CUD- group.
引用
收藏
页数:11
相关论文
共 43 条
  • [31] PREVALENCE AND ODDS OF STROKE IN YOUNG CANCER PATIENTS WITH VS. WITHOUT CANNABIS USE DISORDER (CUD): A CONTEMPORARY NATIONWIDE ANALYSIS IN THE UNITED STATES, 2019
    Jain, A.
    Bansal, P.
    Edusa, S.
    Patta, H. V. Chintalapalli
    Mohammed, A.
    Sagoo, G.
    Vasudev, I.
    Lakkimsetti, M.
    Vyas, A.
    Rupareliya, C.
    Manaktala, P.
    Desai, R.
    INTERNATIONAL JOURNAL OF STROKE, 2023, 18 (03) : 173 - 174
  • [32] Risk of Major Adverse Cardiovascular Events Associated with Concomitant Use of Antidepressants and Non-steroidal Anti-inflammatory Drugs: A Retrospective Cohort Study
    Jeong, Han Eol
    Oh, In-Sun
    Kim, Woo Jung
    Shin, Ju-Young
    CNS DRUGS, 2020, 34 (10) : 1063 - 1074
  • [33] Risk of Major Adverse Cardiovascular Events Associated with Concomitant Use of Antidepressants and Non-steroidal Anti-inflammatory Drugs: A Retrospective Cohort Study
    Han Eol Jeong
    In-Sun Oh
    Woo Jung Kim
    Ju-Young Shin
    CNS Drugs, 2020, 34 : 1063 - 1074
  • [34] Is dependent cannabis use in adult hospitalizations with inflammatory bowel disease associated with major adverse cardiovascular and cerebrovascular events? Insights from National Inpatient Sample Analysis
    Borra, Vamsikalyan
    Borra, Nithya
    Bondi, Gayatri
    Yartha, Sai Goutham R.
    Machineni, Naga Vamsikrishna
    Agarwal, Charu
    Ramasahayam, Karthikeya
    Kuchipudi, Purnachandra Rao
    Mundla, Sravya R.
    Bansal, Prerna
    Bathija, Sagar A.
    Ogbu, Ikechukwu R.
    Desai, Rupak
    CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (04) : 605 - 611
  • [35] Increased Risk for Developing Major Adverse Cardiovascular Events in Stented Chinese Patients Treated with Dual Antiplatelet Therapy after Concomitant Use of the Proton Pump Inhibitor
    Zou, Jian-Jun
    Chen, Shao-Liang
    Tan, Jie
    Lin, Ling
    Zhao, Ying-Ying
    Xu, Hai-Mei
    Lin, Song
    Zhang, Juan
    Fan, Hong-Wei
    Xie, Hong-Guang
    PLOS ONE, 2014, 9 (01):
  • [36] Use of low-dose quetiapine increases the risk of major adverse cardiovascular events: results from a nationwide active comparator-controlled cohort study
    Hojlund, Mikkel
    Andersen, Kjeld
    Ernst, Martin T.
    Correll, Christoph U.
    Hallas, Jesper
    WORLD PSYCHIATRY, 2022, 21 (03) : 444 - 451
  • [37] Rising trends in the burden of cardiovascular comorbidities and major adverse cardiovascular events among young female smokers in two national cohorts studied ten years apart (2017 vs. 2007)
    Desai, Rupak
    Kothawala, Azra
    Bellamkonda, Meena Kumari
    Alle, Naga Ruthvika
    Prattipati, Pramoda
    Biswas, Minakshi
    Sarkar, Kuheli
    Ganesan, Sharmila
    Dey, Debankur
    Bansal, Prerna
    Singh, Sandeep
    Chauhan, Shaylika
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2024, 367 (02): : 105 - 111
  • [38] NATIONWIDE TRENDS IN NAFLD HOSPITALIZATIONS (2016-2019) AMONG YOUNG NON-TOBACCO SMOKERS: THE ROLE OF CANNABIS USE DISORDER AND IMPACT OF SEX, RACE, AND CO-MORBIDITIES
    Pulakurthi, Yashwitha Sai
    Polamarasetty, Harshavardhan
    Mahadevan, Arankesh
    Singh, Prabhsimran
    Ravilla, Jayasree
    Ethakota, Jahnavi
    Pasham, Sudhir R.
    Salian, Rishabh Baskara
    Machineni, Naga Vamsi Krishna
    Desai, Rupak
    GASTROENTEROLOGY, 2024, 166 (05) : S479 - S479
  • [39] Concomitant Use of Antiplatelet Agents and Proton-Pump Inhibitors Increases the Risk of Adverse Cardiovascular Events: A Nationwide Population-Based Cohort Study Using Balanced Operational Definitions
    Yang, Hee Gyu
    Kim, Dong-Kyu
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2023, 10 (06)
  • [40] Risk of major adverse cardiovascular events for concomitant use of clopidogrel and proton pump inhibitors in patients inheriting CYP2C19 loss-of-function alleles: meta-analysis
    Mohitosh Biswas
    Shawonur Rahaman
    Tapash Kumar Biswas
    Baharudin Ibrahim
    International Journal of Clinical Pharmacy, 2021, 43 : 1360 - 1369